BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 20021954)

  • 1. [Analysis of the therapeutic effect of esophagectomy with extended 2-field lymph node dissection for esophageal carcinoma].
    Wu CR; Xue HC; Zhu ZH; Zhang ZB; Geng CY; Ma ZK; Guo Y; Gao J
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):630-3. PubMed ID: 20021954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection.
    Kato H
    Ann Chir Gynaecol; 1995; 84(2):193-9. PubMed ID: 7574380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
    Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
    J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiated surgical therapy of esophageal carcinoma].
    Junginger T; Dutkowski P; Böttger T; Wahl W
    Chirurg; 1995 Jul; 66(7):693-703. PubMed ID: 7545571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lymphadenectomy add anything to the treatment of esophageal cancer?
    Law S; Wong J
    Adv Surg; 1999; 33():311-27. PubMed ID: 10572574
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
    Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
    Lee DH; Kim HR; Kim DK; Park SI; Kim YH
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
    Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
    Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
    Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
    Wang Z; Liu XY; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers.
    Shimada H; Nabeya Y; Matsubara H; Okazumi S; Shiratori T; Shimizu T; Aoki T; Shuto K; Akutsu Y; Ochiai T
    Am J Surg; 2006 Feb; 191(2):250-4. PubMed ID: 16442955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
    Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of lymphatic metastases in superficial squamous cell carcinoma of the esophagus.
    Gotohda N; Nishimura M; Yoshida J; Nagai K; Tanaka N
    Hepatogastroenterology; 2005; 52(61):105-7. PubMed ID: 15783006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
    Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
    Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.